Cancer survivors harboring inherited pathogenic variants in the breast cancer (BC) susceptibility genes <i>BRCA1</i> or <i>BRCA2</i> are at increased risk of ovarian cancer (OC) and also of contralateral BC. The gene discussed is BRCA2; the disease is ovarian carcinoma.